Library Header Image
LSE Research Online LSE Library Services

Differences in costs of and access to pharmaceutical products in the EU

Medical Technology Research Group – LSE Health London School of Economics and Political Science (2011) Differences in costs of and access to pharmaceutical products in the EU. . European Parliament, Brussels. (Submitted)

Full text not available from this repository.


This report reviews the differences in the prices of pharmaceuticals among Member States. It presents an overview of the prices for pharmaceuticals protected by patents as well as those for off-patent pharmaceuticals subject to competition from lower-priced “generic” versions. The report reviews the approaches that Member States have used to regulate the pharmaceutical market on both the supply and demand sides, and assesses evidence regarding the impact of these different approaches on pharmaceutical prices, costcontainment, industry innovation. The report also considers the implications for patient access to pharmaceuticals. The report considers policy options to strengthen coordination among Member States and exchange best practice.

Item Type: Monograph (Report)
Official URL:
Additional Information: © 2011 European Parliament
Divisions: European Institute
Social Policy
LSE Health
Subjects: R Medicine > RA Public aspects of medicine
R Medicine > RS Pharmacy and materia medica
Date Deposited: 31 Jan 2012 12:17
Last Modified: 07 Sep 2021 23:06

Actions (login required)

View Item View Item